Page 5 - ஐரோப்பிய நிறுவனம் ஆஃப் புற்றுநோயியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
COVID-19 vaccines may protect many, but not all, people with suppressed immune systems
sciencemag.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencemag.org Daily Mail and Mail on Sunday newspapers.
WCM-Q researchers investigate student stress at universities in Qatar
thepeninsulaqatar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thepeninsulaqatar.com Daily Mail and Mail on Sunday newspapers.
WCM-Q Researchers Investigate Student Stress At Universities In Qatar
albawaba.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albawaba.com Daily Mail and Mail on Sunday newspapers.
Targeting microRNAs makes cancer stem cells more susceptible to chemotherapies
Researchers in Italy have identified a pair of microRNA molecules that help maintain a population of cancerous stem cells that drive the growth of breast cancers and initiate tumor relapse after treatment. The study, which will be published April 2 in the
Journal of Cell Biology (
JCB), reveals that targeting these microRNAs makes cancer stem cells more susceptible to some chemotherapies and could potentially improve the prognosis of patients with aggressive forms of breast cancer.
Many tumors contain a small population of cancer stem cells that initiate tumor growth and give rise to the various cell types found in tumors. Moreover, because cancer stem cells are often resistant to radio- and chemotherapies, they can survive and promote tumor relapse and metastasis after initial rounds of treatment. In breast cancer, for example, tumors containing a relatively high number of cancer stem cells have a mu
Died: January 20, 2021. PROFESSOR Gordon McVie, who has died aged 75, was a Scottish clinician and campaigner who became one of the world’s leading authorities on the treatment of cancer and, for many years in the UK, was the public face of the battle against it. He believed in fighting the disease on many fronts and in taking every new opportunity to do so. He was a clinician first and foremost, but he was also a researcher, campaigner, educator, publicist, and innovator, renowned as a master of the soundbite. He fought for better treatments, and more money, and as Director General of the Cancer Research Campaign, saw more than 60 new drugs proceed from the lab to clinical trial. Research, he believed, was the key to success and he pushed for many more patients to be involved in trials.